1 / 18

Clinical Decisions in Cavernous Angiomas

Clinical Decisions in Cavernous Angiomas. Issam A. Awad, MD, MSc, FACS, MA (hon) Professor of Neurosurgery Northwestern University Feinberg School of Medicine Evanston Northwestern Healthcare Evanston, Illinois Chairman, Scientific Advisory Board Angioma Alliance (www.angiomaalliance.com).

tjoann
Download Presentation

Clinical Decisions in Cavernous Angiomas

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Decisions in Cavernous Angiomas Issam A. Awad, MD, MSc, FACS, MA (hon) Professor of Neurosurgery Northwestern University Feinberg School of Medicine Evanston Northwestern Healthcare Evanston, Illinois Chairman, Scientific Advisory Board Angioma Alliance (www.angiomaalliance.com)

  2. Confirming the Diagnosis of CM and Assessing Prognosis • Is it a CM? • Is it solitary or multiple/familial? • Is there an associated VM? • Risks and Consequences of hemorrhage?

  3. Projecting Natural Risk of CM • Likelihood of hemorrhage? (consider recent clinical behavior) • Consequences of hemorrhage ( consider lesion location) • Impact of hemorrhage(s) over lifetime (consider host’s life expectancy)

  4. Assessing Management Options • Expectant-- medical therapy, regular surveillance • CM microsurgical excision-- define threshold for intervention (preventive, after one bleed, near disability, etc…) • Other options-- ? radiosurgery

  5. Evaluate Options of Medical Therapy • Seizure control, medicines and side effects • Bleeding risk, consequences • Impact of living with the lesion or with epilepsy-- life decisions, careers, parenting, etc… • Do not “wrap yourself in bubble”-- few real restrictions

  6. Microsurgical Excision of CM • Hemorrhage or other symptoms • Opportunity for “cure” (solitary, no large VM) • Accessibility, approach • Eloquence • Risk-- defines the threshold for choosing surgery

  7. What About Radiosurgery ? • Does not eliminate the lesion • May not alter natural risk • Complications high unless dosimetry is very low (? effective) • Radiation and CM genesis • Truly inaccessible lesions with repeated bleeds (any such CMs?)

  8. Special Considerations for Epilepsy and CM • Single versus multiple lesions and epilepsy • Lesion and seizure concordance--clinical, diagnostic, role of mapping • Lesionectomy, versus lesionectomy “plus” • Control versus cure (lesion-free, seizure-free, medication-free)

  9. Special Considerations for Brainstem CMs • Expensive real estate-- natural risk and treatment risks • Higher stakes, higher threshold-- not surgery at any cost, but do not wait too long • Approach and exposure-- experience • Access, size, hematoma, associated VM-- what is operable?

  10. Special Considerations for Brainstem CMs

  11. Special Consideration for CM with associated VM • Leave alone if large VM and many CMs • Leave alone if extensive VM and minimal CM • Excise CM if large, growing or symptomatic-- preserve the VM, unless very tiny

  12. Special Considerations for Spinal CMs • Not very different from brainstem CMs-- pathoanatomy and clinical sequels • Keep high index of suspicion • Excise if solitary, accessible, growing, symptomatic • Do not wait till advanced symptoms

  13. What About Pregnancy? • CCMs may bleed during pregnancy (more likely ?) • Great majority of patients and lesions have unremarkable pregnancies • Epilepsy and pregnancy-- anticonvulsant medications ESSENTIAL • Expectant management during pregnancy-- be aware and watch CLOSELY

  14. Factors Favoring Surgery Solitary lesion Accessible lesion Symptomatic lesion Growing lesion Long life expectancy Bad consequences of lesion misbehavior Factors Favoring Expectant Management Multiple lesions Associated VMs (large) Deep lesions Longstanding quiescence Shorter life expectancy Risks of surgery Balance of Clinical Decisions

  15. Surgical Adjuncts • Microsurgery, stereotactic guidance • Brain mapping-- preoperative, intraoperative • Skull base approaches • Team experience-- critical care, surgery, rehabilitation

  16. Threshold for Intervention: Wisdom and Experience • Preventive ? • Curative ? • In response to CM misbehavior ? How long? • Threshold of acceptable morbidity of treatment

  17. Threshold for Intervention: Wisdom and Experience • Preventive ? • Curative ? • In response to CM misbehavior ? How long? • Threshold of acceptable morbidity of treatment

  18. Research Directions • Epidemiology, natural history, outcome studies, QOL • Genotyping, genotype-phenotype correlations • Molecular architecture and function in CCM lesions • Molecular mechanisms of lesion genesis and clinical behavior Translational Research: Bedside to bench to patients and loved ones..

More Related